Cargando…
Modeling Hepatitis C Elimination Among People Who Inject Drugs in New Hampshire
IMPORTANCE: The success of direct-acting antiviral therapies for chronic hepatitis C virus (HCV) infection led the World Health Organization to set elimination targets by 2030. For the United States to achieve these benchmarks, public health responses must target high-risk populations, such as peopl...
Autores principales: | Blake, Andrew, Smith, James E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335578/ https://www.ncbi.nlm.nih.gov/pubmed/34342652 http://dx.doi.org/10.1001/jamanetworkopen.2021.19092 |
Ejemplares similares
-
Hepatitis C elimination among people who inject drugs in Mexico during the COVID-19 pandemic
por: Márquez, Lara K., et al.
Publicado: (2022) -
A community-based strategy to eliminate hepatitis C among people who inject drugs in Vietnam
por: Nagot, Nicolas, et al.
Publicado: (2023) -
Risk of New Bloodstream Infections and Mortality Among People Who Inject Drugs With Infective Endocarditis
por: Tan, Charlie, et al.
Publicado: (2020) -
HCV elimination among people who inject drugs. Modelling pre- and post–WHO elimination era
por: Gountas, Ilias, et al.
Publicado: (2018) -
Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago
por: Tatara, Eric, et al.
Publicado: (2022)